AP NEWS

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, PVG, MCHP and COCP

October 8, 2018

NEW YORK, Oct. 08, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

OPKO Health Inc. (NASDAQ: OPK) Class Period: September 26, 2013 to September 7, 2018 Lead Plaintiff Deadline: November 13, 2018

According to the complaint, OPKO Health Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) OPKO and its Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, defendants’ statements about OPKO’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the OPK lawsuit: http://www.kleinstocklaw.com/pslra-1/opko-health-inc-loss-submission-form?wire=3

Pretium Resources Inc. (NYSE: PVG) Class Period: July 21, 2016 to September 6, 2018 Lead Plaintiff Deadline: November 6, 2018

The complaint alleges that throughout the class period Pretium Resources Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Brucejack Project is not a high-grade, high-output mine; and (2) as a result of the foregoing, defendants’ statements about Pretium’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

On January 23, 2018, Pretium disclosed lower gold production than previously disclosed. Then, on September 6, 2018, Viceroy Research reported that the company’s “reported grades and reserves are significantly inflated, a much greater amount of waste is being dumped into local lakes, and more explosives are being utilized” and alleged that “management is scrambling to find consistent, high-grade ore to maintain the charade that its debt and equity are viable.”

Get additional information about the PVG lawsuit: http://www.kleinstocklaw.com/pslra-1/pretium-resources-inc-loss-submission-form?wire=3

Microchip Technology Inc. (NASDAQGS: MCHP) Class Period: March 2, 2018 to August 9, 2018 Lead Plaintiff Deadline: November 16, 2018

Microchip Technology Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Microsemi’s financial performance was underperforming Microchip’s expectations; and (2) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, including positive statements about Microsemi, were materially misleading and/or lacked a reasonable basis.

Get additional information about the MCHP lawsuit: http://www.kleinstocklaw.com/pslra-1/microchip-technology-inc-loss-submission-form?wire=3

Cocrystal Pharma, Inc. (NASDAQCM: COCP) Class Period: September 23, 2013 to September 7, 2018 Lead Plaintiff Deadline: November 19, 2018

Throughout the class period, Cocrystal Pharma, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) defendants were engaged in a pump-and-dump scheme to artificially inflate Cocrystal’s stock price; (2) this illicit scheme would result in governmental scrutiny, including from the SEC; (3) defendants failed to abide by SEC disclosure regulations; and (4) as a result, defendants’ statements about Cocrystal’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the COCP lawsuit: http://www.kleinstocklaw.com/pslra-1/cocrystal-pharma-inc-formerly-biozone-pharmaceuticals-inc-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:Joseph Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118 jk@kleinstocklaw.com Telephone: (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.com

AP RADIO
Update hourly